Latest Amphetamines Stories
Scientists are reporting development of three promising formulations that could be used in a vaccine to treat methamphetamine addiction â€” one of the most serious drug abuse problems in the U.S.
WASHINGTON, May 9, 2011 /PRNewswire-USNewswire/ -- The following is a statement by Scott M.
PHILADELPHIA, April 28, 2011 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced positive results from a signal-finding study of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules (CII) assessing its effect in a prospective examination of adults with negative symptom predominant schizophrenia.
NORTH LIBERTY, Iowa, April 25, 2011 /PRNewswire/ -- KemPharm, Inc.
WARREN, N.J., April 25, 2011 /PRNewswire/ -- MonoSol Rx, LLC ("MonoSol Rx"), the developer of PharmFilmÂ® drug delivery technology, today announced that the Company has entered into a development and commercialization partnership with KemPharm, a biopharmaceutical company focused on the discovery and development of new, safer therapies for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), pain, and cardiovascular disease. Under terms of the agreement, the companies will...
Dutch researchers have found that long term use of the drug ecstasy can cause structural brain damage.
DUBLIN and PHILADELPHIA, April 6, 2011 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that its subsidiary Shire LLC has filed a lawsuit in the U.S.
Australian researchers studying the effects of drug use in the real world, attended parties where people were using a particular drug known as ecstasy (which often also contains a variety of other drugs), discovering that the drug posed far greater risk on usersâ€™ brains than anyone previously believed.
Teens and young adults are coming up with creative ways to use legal substances to achieve a high.
DUBLIN, Ireland and PHILADELPHIA, February 24, 2011 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that its subsidiaries Shire LLC and Shire Development Inc.
- a meat pie that is usually eaten at Christmas in Quebec